A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Froguel, Philippe ^a,b   Ndiaye, Ndeye Coumba ^c   Bonnefond, Amélie ^a,c   Bouatia Naji, Nabila ^a   Dechaume, Aurélie ^a   Siest, Gérard ^c   Herbeth, Bernard ^c   Falchi, Mario ^b   Bottolo, Leonardo ^b   Guéant Rodriguez, Rosa Maria ^d   Lecoeur, Cécile ^a   Langlois, Michel R ^e,f   Labrune, Yann ^a   Ruokonen, Aimo ^g   El Shamieh, Said ^c   Stathopoulou, Maria G ^c   Morandi, Anita ^a,h   Maffeis, Claudio ^h   Meyre, David ^a   Delanghe, Joris R ^e   Jacobson, Peter ⁱ   Sjöström, Lars ⁱ   Carlsson, Lena M S ⁱ   Walley, Andrew ^b   Elliott, Paul ⁱ   Jarvelin, Marjo Riita ^g,j,k   Dedoussis, George V ^c,l   Visvikis Siest, Sophie ^c,m   more..

^a Institut Pasteur de Lille   (France)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITÉ DE LORRAINE   (France)

^d INSERM   (France)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f GHENT UNIVERSITY   (Belgium)

^g UNIVERSITY OF OULU   (Finland)

^h Regional Centre for Juvenile Diabetes   (Italy)

ⁱ UNIVERSITY OF GOTHENBURG   (Sweden)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

^k NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^l HAROKOPIO UNIVERSITY   (Greece)

^m UNIVERSITY HOSPITAL OF NANCY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; HAPTOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA;

ADOLESCENT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HAPTOGLOBIN GENE; HUMAN; INFLAMMATION; MALE; PHENOTYPIC VARIATION; POLYMORPHIC LOCUS; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; BLOOD; CARDIOVASCULAR DISEASE; GENETICS; METABOLISM; RISK FACTOR;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; CARDIOVASCULAR DISEASES; CHILD; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPTOGLOBINS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84857769490     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032327     Document Type: Article

References (53)

1. Gabay C, Kushner I, (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340: 448-454.
2. Bowman BH, Kurosky A, (1982) Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 12: 189-261 453-184.
3. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, et al. (1996) Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem 34: 517-520.
4. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, et al. (2000) Reference distributions for the positive acute phase serum proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal 14: 284-292.
5. Quaye IK, (2008) Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 102: 735-742.
6. Okazaki T, Yanagisawa Y, Nagai T, (1997) Analysis of the affinity of each haptoglobin polymer for hemoglobin by two-dimensional affinity electrophoresis. Clin Chim Acta 258: 137-144.
7. Braeckman L, De Bacquer D, Delanghe J, Claeys L, De Backer G, (1999) Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables. Atherosclerosis 143: 383-388.
8. Balestrieri M, Cigliano L, Simone ML, Dale B, Abrescia P, (2001) Haptoglobin inhibits lecithin-cholesterol acyltransferase in human ovarian follicular fluid. Mol Reprod Dev 59: 186-191.
9. Salvatore A, Cigliano L, Carlucci A, Bucci EM, Abrescia P, (2009) Haptoglobin binds apolipoprotein E and influences cholesterol esterification in the cerebrospinal fluid. J Neurochem 110: 255-263.
10. Kasvosve I, Speeckaert MM, Speeckaert R, Masukume G, Delanghe JR, (2010) Haptoglobin polymorphism and infection. Adv Clin Chem 50: 23-46.
11. Langlois MR, Delanghe JR, (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42: 1589-1600.
12. Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, et al. (2003) Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ Res 92: 1193-1200.
13. Rother RP, Bell L, Hillmen P, Gladwin MT, (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. Jama 293: 1653-1662.
14. Mohapatra MK, Mohanty S, Mohanty BK, Sahu GN, (1999) Hypohaptoglobinaemia as a biochemical and epidemiological marker of falciparum malaria. J Assoc Physicians India 47: 874-877.
15. Eisaev BA, (1995) [Results of the treatment of patients with recurrence of pulmonary tuberculosis with different types of haptoglobin]. Probl Tuberk pp. 20-22.
16. Delanghe JR, Langlois MR, Boelaert JR, Van Acker J, Van Wanzeele F, et al. (1998) Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. Aids 12: 1027-1032.
17. Friis H, Gomo E, Nyazema N, Ndhlovu P, Krarup H, et al. (2003) Iron, haptoglobin phenotype, and HIV-1 viral load: a cross-sectional study among pregnant Zimbabwean women. J Acquir Immune Defic Syndr 33: 74-81.
18. Bacq Y, Schillio Y, Brechot JF, De Muret A, Dubois F, et al. (1993) [Decrease of haptoglobin serum level in patients with chronic viral hepatitis C]. Gastroenterol Clin Biol 17: 364-369.
19. Louagie HK, Brouwer JT, Delanghe JR, De Buyzere ML, Leroux-Roels GG, (1996) Haptoglobin polymorphism and chronic hepatitis C. J Hepatol 25: 10-14.
20. Van Vlierberghe H, Delanghe JR, De Bie S, Praet M, De Paepe A, et al. (2001) Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 13: 1077-1081.
21. Delanghe J, Langlois M, Ouyang J, Claeys G, De Buyzere M, et al. (1998) Effect of haptoglobin phenotypes on growth of Streptococcus pyogenes. Clin Chem Lab Med 36: 691-696.
22. Rohde KH, Dyer DW, (2004) Analysis of haptoglobin and hemoglobin-haptoglobin interactions with the Neisseria meningitidis TonB-dependent receptor HpuAB by flow cytometry. Infect Immun 72: 2494-2506.
23. Calderoni DR, Andrade Tdos S, Grotto HZ, (2006) Haptoglobin phenotype appears to affect the pathogenesis of American trypanosomiasis. Ann Trop Med Parasitol 100: 213-221.
24. Speeckaert R, Speeckaert MM, Padalko E, Claeys LR, Delanghe JR, (2009) The haptoglobin phenotype is associated with the Epstein-Barr virus antibody titer. Clin Chem Lab Med 47: 826-828.
25. Asleh R, Guetta J, Kalet-Litman S, Miller-Lotan R, Levy AP, (2005) Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo. Circ Res 96: 435-441.
26. Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, et al. (2000) Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med 343: 969-970.
27. Ryndel M, Behre CJ, Brohall G, Prahl U, Schmidt C, et al. (2010) The haptoglobin 2-2 genotype is associated with carotid atherosclerosis in 64-year old women with established diabetes. Clin Chim Acta 411: 500-504.
28. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G, (2009) Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Ann Med 41: 522-32.
29. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G, (2010) Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Atherosclerosis 213: 299-305.
30. Maeda N, (1985) Nucleotide sequence of the haptoglobin and haptoglobin-related gene pair. The haptoglobin-related gene contains a retrovirus-like element. J Biol Chem 260: 6698-6709.
31. Koda Y, Soejima M, Yoshioka N, Kimura H, (1998) The haptoglobin-gene deletion responsible for anhaptoglobinemia. Am J Hum Genet 62: 245-252.
32. Igl W, Johansson A, Wilson JF, Wild SH, Polasek O, et al. (2010) Modeling of environmental effects in genome-wide association studies identifies SLC2A2 and HP as novel loci influencing serum cholesterol levels. PLoS Genet 6: e1000798.
33. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
34. Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, et al. (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358: 2107-2116.
35. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, et al. (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302: 49-57.
36. Turner SJ, Ketch TR, Gandhi SK, Sane DC, (2008) Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes. Am Heart J 155: 806-816.
37. Marcovina SM, Crea F, Davignon J, Kaski JC, Koenig W, et al. (2007) Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools. J Intern Med 261: 214-234.
38. Raitakari OT, Juonala M, Kahonen M, Taittonen L, Laitinen T, et al. (2003) Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Jama 290: 2277-2283.
39. Mahoney LT, Burns TL, Stanford W, Thompson BH, Witt JD, et al. (1996) Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol 27: 277-284.
40. Bouatia-Naji N, Rocheleau G, Van Lommel L, Lemaire K, Schuit F, et al. (2008) A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science 320: 1085-1088.
41. Visvikis-Siest S, Siest G, (2008) The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases. Clin Chem Lab Med 46: 733-747.
42. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, Sparso T, Holmkvist J, et al. (2009) A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 41: 89-94.
43. Friedewald WT, Levy RI, Fredrickson DS, (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
44. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, et al. (1991) Body Mass Index variations: centiles from birth to 87 years. Eur J Clin Nutr 45: 13-21.
45. Papoutsakis C, Vidra NV, Hatzopoulou I, Tzirkalli M, Farmaki AE, et al. (2007) The Gene-Diet Attica investigation on childhood obesity (GENDAI): overview of the study design. Clin Chem Lab Med 45: 309-15.
46. Jarvelin MR, Elliott P, Kleinschmidt I, Martuzzi M, Grundy C, et al. (1997) Ecological and individual predictors of birthweight in a northern Finland birth cohort 1986. Paediatr Perinat Epidemiol 11: 298-312.
47. Koch W, Latz W, Eichinger M, Roguin A, Levy AP, et al. (2002) Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin Chem 48: 1377-1382.
48. Donner A, Koval JJ, (1981) A multivariate analysis of family data. Am J Epidemiol 114: 149-154.
49. Lange K, Weeks D, Boehnke M, (1988) Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 5: 471-472.
50. Lange K, Westlake J, Spence MA, (1976) Extensions to pedigree analysis. III. Variance components by the scoring method. Ann Hum Genet 39: 485-491.
51. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
52. Carlsson LM, Jacobson P, Walley A, Froguel P, Sjostrom L, et al. (2009) ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease. Biochem Biophys Res Commun 382: 309-314.
53. Trayhurn P, Wood IS, (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92: 347-355.